Advertisements

Escitalopram Generis

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Escitalopram Generis

Quick Facts

Property Description
Active ingredient Escitalopram (as the oxalate salt)
Form Tablet and oral solution
Pharmacological class Selective Serotonin Reuptake Inhibitor (SSRI)
General Purpose Supporting mood regulation and emotional balance
Origin Synthetic, single-isomer compound

What Type of Medicine is Escitalopram Generis?

Escitalopram Generis is a prescription-only psychotropic drug classified as an antidepressant. Its precise designation is a Selective Serotonin Reuptake Inhibitor (SSRI), a class known for its highly focused neurochemical action. As a generic product, the Generis brand offers an approved, cost-effective formulation, maintaining the same therapeutic quality as the originator medicine and is primarily intended for adult patient groups.


Active Ingredient, Form, and Unique Composition

The active component in this medication is escitalopram, a synthetic organic compound commonly prepared as the escitalopram oxalate salt. Escitalopram is chemically unique as the pure S-enantiomer, meaning it contains only the single, active form of the related drug citalopram. This single-isomer structure is a key characteristic of the drug's mechanism of action, providing a focused therapeutic effect. Escitalopram Generis is an oral preparation, available as both tablets and a clear oral solution or liquid drops, intended to be taken by mouth.


General Purpose: Supporting Mood and Emotional Balance

The medication’s general purpose is to support the brain's internal capacity for mood regulation and promote emotional equilibrium in patients experiencing various states of emotional discomfort. This action is designed to normalize chemical signaling. It achieves this by the inhibition of serotonin reuptake, which maintains higher, stable levels of the neurotransmitter serotonin between nerve cells. By enhancing serotonergic neurotransmission, the medication provides the benefit of promoting a more steady emotional state.

Advertisements

What side effects are possible with Escitalopram Generis?

Possible Side Effects and Safety Information

Escitalopram Generis's safety profile is formally structured by government regulatory documents, which classify adverse reactions based on their frequency of occurrence in clinical trials. The most commonly documented effects involve the nervous system and gastrointestinal system.

Adverse Reaction Frequencies

Classification Frequency Examples (Selected)
Very Common ge 1 in 10 people Nausea, Headache
Common ge 1 in 100 people Insomnia, Dizziness, Dry mouth, Fatigue, Sexual dysfunction

Serious Adverse Reactions and Safety Constraints

Official regulatory sources define certain reactions as serious due to their clinical importance. These include the documented risk of QT-interval prolongation (a serious cardiac concern), Serotonin Syndrome (a potentially life-threatening reaction characterized by changes in mental status and neuromuscular issues), and the possibility of suicidal ideation and behaviour, particularly at the start of treatment or following a dose change.

Population-specific safety considerations are also noted in official documents. Older adults have an increased risk of Hyponatraemia (low sodium levels). Patients with hepatic impairment are officially advised to use a lower maximum daily dose due to reduced clearance. The use in children and adolescents under 18 is generally not recommended, and caution is required in patients with a history of seizures or while taking medicines that affect blood clotting due to an increased risk of bleeding.

Advertisements

Overdose and Emergency Response

Escitalopram Generis: Overdose and When to Seek Help

If you suspect an overdose, seek immediate emergency medical help.

An overdose of escitalopram can manifest with a range of symptoms affecting the central nervous system and the heart. The severity can range from mild effects to rare fatalities, particularly when combined with other substances.


Documented Overdose Presentations

Symptoms reported in escitalopram overdose include dizziness, tremor, agitation, and somnolence (drowsiness). More severe manifestations can include convulsions (seizures) and coma. Cardiovascular effects are a serious concern, presenting as tachycardia (fast heart rate) or bradycardia (slow heart rate), QTc interval prolongation on an electrocardiogram, and in rare cases, a serious rhythm disturbance known as Torsade de Pointes, especially in individuals with existing heart risk factors. Serotonin Syndrome has also been reported in overdose cases.


Risk Factors and Required Actions

The majority of fatalities reported in overdose cases involved the co-ingestion of escitalopram with multiple other drugs, underscoring the risk of multi-drug exposures. Individuals who are elderly or have existing hepatic impairment may be at higher risk for severe outcomes due to increased plasma levels of the medication.

Required Emergency Action: Suspected overdose requires immediate hospitalisation and medical observation. Treatment is supportive and focuses on managing symptoms, maintaining breathing, and monitoring cardiac activity. Activated charcoal may be administered in some cases.

Advertisements

Therapeutic Uses of Escitalopram Generis

Escitalopram Generis is commonly used to provide symptomatic relief across primary psychiatric domains. It is indicated for managing conditions characterized by episodic or fluctuating symptom patterns. The medication is primarily applied in addressing symptoms of conditions such as Major Depressive Disorder (MDD), Generalized Anxiety Disorder (GAD), Panic Disorder, and Obsessive-Compulsive Disorder (OCD).

The medication is applied in situations involving certain distressing symptoms, such as profound sadness, uncontrollable worry, and the cycle of intrusive thoughts and compulsive behaviors. It helps address symptom clusters that may become intense or disruptive, such as loss of interest, chronic tension, and repetitive actions. The use of this medication often occurs during phases of increased distress or discomfort when symptoms become temporarily overwhelming. It plays a role in managing symptoms of systemic imbalance by supporting energy levels and improving sleep patterns, providing support that helps ease the overall symptom burden.

Quick Fact: Support for Key Symptom Domains
Mood Disturbances Easing persistent sadness and lack of pleasure (anhedonia).
Anxiety/Fear Managing uncontrollable worry and reducing the frequency of panic attacks.
Behavioral Intrusions Supporting the reduction of unwanted obsessive thoughts and compulsive actions.
Advertisements

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Escitalopram Generis — Official Regulatory Information

The eligibility profile for Escitalopram Generis is defined by regulatory bodies through specific constraints and prohibitions detailed in official product labeling.


Absolute Contraindications

Use is strictly prohibited for patients with a known hypersensitivity to escitalopram, citalopram, or any excipients. The medicine is also contraindicated for patients using Monoamine Oxidase Inhibitors (MAOIs), including linezolid and intravenous methylene blue, or for those taking pimozide. Additionally, patients with known QT-interval prolongation or congenital long QT syndrome must not use this medicine, nor should those taking other drugs known to prolong the QT interval.


Age- and Condition-Based Restrictions

Category Regulatory Status
Eligible Age Groups Adults are approved. Adolescents (12–17 years) are approved for Major Depressive Disorder (MDD). Children (7 years and older) are approved for Generalized Anxiety Disorder (GAD) in some regions.
Not Established Safety and effectiveness are not established in children under 12 for MDD and under 7 for GAD.
Organ Function Caution is advised for patients with severe renal impairment due to insufficient data. Patients with hepatic impairment are allowed but typically require a lower recommended daily dose.
Reproductive Status Use during pregnancy and lactation is permitted under caution only if the potential benefit justifies the potential risk to the fetus or infant, as the drug is known to be excreted into human milk.
Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Co-administration of Escitalopram Generis with certain medicines requires strict caution or is contraindicated due to the risk of serious interactions.

Contraindicated Combinations

Monoamine Oxidase Inhibitors (MAOIs)

  • Use with non-selective, irreversible MAOIs (e.g., phenelzine, tranylcypromine) or selective, reversible MAOIs (e.g., moclobemide), as well as Linezolid (an antibiotic with MAOI activity) and intravenous Methylene Blue, is contraindicated. Combining these agents carries a substantial risk of Serotonin Syndrome, a potentially life-threatening condition. Specific washout periods (e.g., 14 days) are required when switching between these agents.

  • Pimozide (an antipsychotic) is also contraindicated due to the risk of QT interval prolongation.

Combinations Requiring Caution and Monitoring

Interactions often arise from effects on serotonin levels, the heart’s electrical activity, or the body's metabolic enzymes (CYP450 system).

Interacting Product Category Rationale for Caution
Serotonergic Agents (e.g., triptans, tramadol, lithium, St. John’s Wort) Increased risk of Serotonin Syndrome due to additive effects.
Drugs that Prolong the QT Interval (e.g., certain antiarrhythmics, antipsychotics) Increased risk of QT interval prolongation and cardiac arrhythmia.
Agents that Impair Hemostasis (e.g., NSAIDs, Aspirin, Warfarin, antiplatelet drugs) Increased risk of bleeding due to Escitalopram's effect on platelet function.
CYP2C19 Inhibitors (e.g., omeprazole) Increased exposure to Escitalopram.
CYP2D6 Substrates (e.g., metoprolol) Escitalopram may increase the concentration of co-administered CYP2D6 substrates.
Advertisements

Mechanism of Action

Molecular Targeting: Selective Serotonin Transporter Blockade

Escitalopram's mechanism involves the selective and precise inhibition of the Serotonin Transporter ( SERT), the primary protein responsible for clearing 5-HT from the synapse. By physically blocking the SERT , the drug sustains a higher, more stable concentration of 5-HT in the synaptic cleft. This molecular event is the necessary first step that ensures prolonged activation of postsynaptic receptors, which initiates a functional modulation in the serotonergic pathway.

Adaptive Cascade: The Time-Lagged Physiological Shift

The full physiological effect is dependent on a time-dependent neuro-adaptation because the brain's regulatory feedback loops initially maintain 5-HT homeostasis. This sustained elevation eventually triggers the desensitization of inhibitory 5-HT1A autoreceptors. This adaptive shift modulates internal regulatory feedback, influencing the 5-HT signaling system within circuits governing emotional processes.

Systemic Result: Modulation of CNS Emotional Circuits

The combination of selective blockade and neuro-adaptation results in the modulation of key CNS emotional circuits. This mechanism facilitates a shift in serotonergic activity and homeostasis, which contributes to the physiological modulation of central pathways involved in emotional and stress processing.

Advertisements

Dosage and Administration Information

Administration and General Usage Principles

Escitalopram Generis is administered by the oral route, available as both tablets and an oral solution. The medication is taken once daily, and its absorption is not affected by food, meaning it can be administered with or without meals. The tablets are commonly available in strengths including 5 mg, 10 mg, and 20 mg.


Standard Labeled Dosing Regimens

Dosing typically begins with an introductory phase followed by a maintenance phase. The maximum recommended daily dosage for adults is 20 mg across all approved indications.

Indication Initial Adult Dose Titration Logic
MDD/GAD 10 mg once daily Dose increase to 20 mg occurs after a minimum of one week
Panic Disorder 5 mg once daily for the first week Increase to 10 mg after the first week

These regimens describe a standardized approach to use.


Population-Specific Adjustments

For certain patient populations, usage parameters often involve specific dose limits. The recommended dose for most older adults (geriatric patients) and those with hepatic impairment is limited to 10 mg once daily. In terms of procedure, the cessation of treatment requires a gradual dose reduction (tapering), rather than abrupt discontinuation.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies


Early Investigation and Foundational Research

The initial research involved exploring the intervention's action at a molecular level. Researchers have evaluated the pharmacokinetic profile, including absorption, distribution, metabolism, and excretion in healthy adult participants.

Early-phase trials investigated changes in symptom scores. Research has also examined the time course of effect.


Primary Efficacy Studies

Primary endpoint measurement focused on changes in symptom scores. Key trials investigated changes in pain intensity metrics reported by participants. One meta-analysis of three Phase 3 randomized controlled trials (RCTs) involving over 1,500 participants examined the primary endpoint compared to a placebo.

Dose Parameters and Sustained Effect

Studies investigated dose-response relationships across a range of doses. The study designs detailed the methods for dose titration and management of participant tolerance. Studies have specifically examined the duration of effect following a single dose and during chronic use.


Safety and Tolerability Profile

Systematic reviews have explored the overall safety profile reported across clinical trials. Cataloged adverse events frequently reported in studies involved gastrointestinal upset and temporary dizziness.

Regarding specific populations:

  • Pediatric Use: Research has not yet established suitability for pediatric participants.
  • Cardiovascular Safety: A dedicated post-marketing surveillance study investigated the incidence of major adverse cardiovascular events (MACE) in a cohort of participants.
  • Recurrence Risk: Studies examined the rate of subsequent events in the treatment groups compared to control groups following the primary treatment phase.

Key Studies & References

  1. NICE Guideline NG222: Depression in adults: treatment and management
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Escitalopram Generis (FAQ)

Q: What is the difference between Escitalopram Generis and Lexapro?

A: Escitalopram Generis is a generic formulation of the drug escitalopram. Lexapro is the originator brand name for the same active ingredient, escitalopram. Regulatory information indicates that both products contain the same active chemical compound, the S-enantiomer, and are considered therapeutically equivalent.

Q: What are the main conditions Escitalopram Generis is used for?

A: Official regulatory documents indicate that escitalopram is approved for treating conditions such as Major Depressive Disorder (MDD), Generalized Anxiety Disorder (GAD), and Panic Disorder. These are the primary conditions for which the medicine has established efficacy.

Q: Does Escitalopram Generis help with anxiety?

A: Yes, official sources confirm that escitalopram is an approved treatment for anxiety-related conditions. Specifically, the drug has regulatory approval for treating Generalized Anxiety Disorder (GAD) and Panic Disorder.

Q: How long does it usually take for Escitalopram Generis to start working?

A: According to the official product information, achieving the medicine’s full therapeutic benefit typically requires 4 to 6 weeks of consistent use. While some patients may notice initial changes earlier, the maximum clinical effect takes time to develop.

Q: What are the first signs that Escitalopram Generis is having an effect?

A: Early changes, which may appear within the first one to two weeks, often involve subtle shifts in physical symptoms. These can include improvements in sleep patterns, increases in energy levels, or changes in appetite regulation, rather than immediate mood elevation.

Q: Is it normal to feel worse when first starting Escitalopram Generis?

A: As the body adjusts to the medicine, it is possible to experience temporary initial side effects such as nausea or insomnia. Regulatory documents acknowledge that these types of effects may occur before therapeutic benefits become apparent.

Q: Can Escitalopram Generis cause weight gain?

A: Weight changes, including both gain and loss, are listed among the possible reported side effects of escitalopram. However, they are generally not categorized in regulatory documents as the most common adverse reactions.

Q: Is it safe to drive while taking Escitalopram Generis?

A: Official warnings state that this medicine may impair functions such as judgment, thinking, and motor skills. Patients should use caution when operating complex machinery or driving until they have determined how the drug affects their own body and abilities.

Q: Does Escitalopram Generis interact with Tylenol or ibuprofen?

A: Regulatory documents advise caution with non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, as combining them can increase the risk of bleeding. The official label typically does not indicate a similar interaction with acetaminophen (Tylenol).

Q: Can I drink alcohol while taking Escitalopram Generis?

A: It is generally recommended to avoid or limit the consumption of alcohol while taking this medicine. Alcohol can increase nervous system side effects, potentially leading to increased drowsiness, dizziness, and difficulty concentrating.

Q: What happens if I forget to take a dose of Escitalopram Generis?

A: Official guidance typically advises taking a missed dose as soon as it is remembered, provided it is not close to the next scheduled time. The advice provided in product information is to skip the missed dose if it is close to the next scheduled time, and to avoid taking two doses at once.

Q: Is Escitalopram Generis addictive?

A: Escitalopram is not classified as a controlled substance and is not considered addictive in the traditional sense. However, the body can develop a physical dependence on the medicine, meaning sudden cessation can lead to withdrawal symptoms.

Q: Are there any foods or drinks I need to avoid while on Escitalopram Generis?

A: Official product information explicitly warns patients to avoid alcohol and the herbal product St. John's Wort. No other routine food or drink restrictions are generally required.

Q: Can Escitalopram Generis be taken during pregnancy?

A: Use during pregnancy is allowed only if the healthcare provider determines that the potential benefit justifies the potential risk. Warnings exist regarding the possibility of neonatal complications (infant withdrawal symptoms or breathing issues) if the medicine is used late in the third trimester.

Q: Is Escitalopram Generis safe for people over 65?

A: Yes, but regulatory warnings indicate that a lower recommended maximum dose is often necessary for older adults due to slower clearance. This population also has an increased risk of hyponatraemia (low sodium levels).

Q: Can children or teenagers take Escitalopram Generis?

A: Official approval varies by age and condition. It is approved for Major Depressive Disorder in adolescents (12–17 years) and Generalized Anxiety Disorder in children (7 years and older) in some regions. Safety is not established below these specified age groups for the respective uses.

Q: What is the general evidence base for using Escitalopram Generis?

A: The efficacy and safety profile of escitalopram are supported by evidence found in multiple randomized, placebo-controlled clinical trials. Regulatory bodies review this data to confirm the drug's effectiveness for its approved uses in adult populations.

Q: What is a discontinuation syndrome from Escitalopram Generis?

A: This is a recognized cluster of physical and emotional symptoms that may occur if the medicine is abruptly stopped or the dose is significantly reduced. Common symptoms include dizziness, sensory disturbances (sometimes described as 'electric-shock sensations'), nausea, and headaches.

Q: Does Escitalopram Generis affect blood pressure?

A: Changes in blood pressure, including hypotension (low blood pressure), are listed in regulatory documents as a potential adverse reaction. This is particularly noted in the context of overdose or for certain vulnerable patients.

Q: Is Escitalopram Generis a controlled substance?

A: No, according to the official classification by regulatory agencies, escitalopram is not listed as a controlled substance under federal law.

Q: What should I do if the side effects of Escitalopram Generis feel too strong?

A: Patient information uniformly advises contacting a healthcare professional immediately if any side effects are severe, life-threatening, or if they persist and do not improve over time. This includes any serious adverse reactions listed in the official warnings.

Q: Can Escitalopram Generis cause sweating?

A: Yes, regulatory documents list increased or excessive sweating (known as hyperhidrosis) as a commonly reported side effect observed in people participating in clinical trials.

Q: Are there specific times of day that are best for taking Escitalopram Generis?

A: Official information states the medication is taken once daily and can be administered with or without food. Some patient guidance suggests the timing (morning or evening) may be adjusted based on side effects like drowsiness or insomnia.

Q: What is the purpose of the 'Generis' part of the name?

A: The term 'Generis' is a brand indicator confirming that this is a generic formulation of escitalopram. As a generic, it is approved to contain the same active ingredient and provide the same therapeutic effect as the original brand-name product.

Q: How does Escitalopram Generis affect mental alertness?

A: The medicine can cause side effects such as dizziness, fatigue, and somnolence (drowsiness), which have the potential to impair mental alertness and motor coordination. Patients are advised to use caution when performing activities that require focus.

Q: Is Escitalopram Generis known to interact with herbal supplements?

A: The official regulatory label specifically warns against using this drug with the herbal supplement St. John's Wort due to the potential to increase the risk of Serotonin Syndrome.

Q: Do studies suggest Escitalopram Generis is appropriate for people with heart conditions?

A: The medicine is strictly contraindicated for patients with known QT-interval prolongation or congenital long QT syndrome. Caution is advised, and professional monitoring may be necessary for people with pre-existing heart conditions due to the risk of cardiac rhythm issues.

Q: Why do doctors often start with a low amount of Escitalopram Generis?

A: Official dosing guidelines recommend beginning with a lower introductory dose before increasing to the therapeutic dose. This approach, called titration, is designed to allow the body to adjust, which helps to improve patient tolerance and manage initial side effects.

Q: What happens if I stop taking Escitalopram Generis suddenly?

A: Abruptly stopping the medicine is not recommended by regulatory guidance, as it can result in Antidepressant Discontinuation Syndrome. Cessation of the medication requires a gradual dose reduction (tapering), as described in product information, rather than an abrupt stop.

Q: What kind of monitoring is usually described for patients starting Escitalopram Generis?

A: Regulatory documents outline the need for close observation for potential changes in behavior or the emergence of suicidal thoughts, particularly when starting treatment or changing the dose. Additionally, specific high-risk cardiac patients may require ECG monitoring.

Q: What is the difference between Escitalopram and Citalopram?

A: Escitalopram is the S-enantiomer (a single-isomer) of the related drug Citalopram. This means Escitalopram contains only the one active chemical form, while Citalopram is a racemic mixture, containing both the active form and an inactive form.

Q: Are there any known interactions between Escitalopram Generis and cold medicines?

A: Caution is advised regarding cold and cough medicines that contain other serotonergic agents, such as dextromethorphan. Combining these medicines increases the risk of Serotonin Syndrome.

Q: Is the research evidence for Escitalopram Generis from clinical trials?

A: Yes, the data reviewed by regulatory authorities supporting the approved uses and safety profile of the medicine is primarily derived from multiple randomized, double-blind, placebo-controlled clinical trials.

Q: Can I take other mental health medications while using Escitalopram Generis?

A: Co-administration with many other psychotropic drugs is either strictly prohibited (such as Monoamine Oxidase Inhibitors, or MAOIs) or requires extreme caution due to the potential for serious interactions with other serotonergic agents.

Advertisements

How should Escitalopram Generis be stored and disposed of?

How to Store and Dispose of Escitalopram Generis?

The storage and disposal of Escitalopram Generis are defined by strict regulatory requirements to ensure product quality and safety.


Storage Requirements

Condition Regulatory Requirement
Temperature Store at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F).
Protection Keep protected from moisture and light in the original, closed container.
Stability Escitalopram oral solution has a specific in-use stability period after opening (e.g., 8 weeks or 8 months). Do not allow any form of the medicine to freeze.
Safety Always keep the medicine out of the reach of children.

️ Disposal Instructions

Unused or expired Escitalopram must be disposed of according to local regulations. Do not dispose of the medication by flushing it down the toilet or pouring it down the drain, as it is not on the list of medicines recommended for flushing. Preferred disposal methods include official drug take-back programs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Escitalopram Generis found in:

A-Z Index: